Американська діабетична асоціація. Стандарти медичної допомоги при діабеті-2021. Глава 3. Профілактика або відтермінування діабету 2 типу





Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.

Lindstr¨om J, Ilanne-Parikka P, Peltonen M, et al.; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-9.

Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2:474-80.

Nathan DM, Bennett PH, Crandall JP, et al.; Research Group. Does diabetes prevention translateintoreducedlong-termvascularcomplications of diabetes? Diabetologia. 2019;62: 1319-28.

Gong Q, Zhang P, Wang J, et al.; Da Qing DiabetesPreventionStudyGroup.Morbidityand mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7:452-61.

Knowler WC, Fowler SE, Hamman RF, et al.; DiabetesPre­­ventionProgramResearchGroup. 10-year follow-up of dia­­betes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-86.

Nathan DM, Barrett-Connor E, Crandall JP, et al. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascularcomplications: theDPPOutcomes Study. Lancet Diabetes Endocrinol. 2015;3:866-75.

Diabetes Prevention Program [DPP] Research Group. The Diabetes Prevention Program [DPP]: description of lifestyle intervention. Diabetes Care. 2002;25:2165-71.

Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102-7.

Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42:731-54.

Department of Health and Human Services and Department of Agriculture. Dietary Guidelines for Americans 2015–2020, Eighth Edition. Accessed5October2020.Availablefromhttps:// health.gov/dietaryguidelines/2015/guidelines

Salas-Salvad´o J, Guasch-Ferr´e M, Lee C-H, Estruch R, Clish CB, Ros E. Protective effects of the Mediterranean diet on type 2 diabetes and metabolic syndrome. J Nutr. 2016;146:920S-7S.

Bloomfield HE, Koeller E, Greer N, MacDonald R, Kane R, Wilt TJ. Effects on health outcomes of a Mediterranean diet with no restriction on fat intake: a systematic review and meta-analysis. Ann Intern Med. 2016;165:491-500.

Estruch R, Ros E, Salas-Salvad´o J, Covas M-I, Corella D, Ar´os F, et al. Primary prevention of cardiovasculardiseasewithaMediterraneandiet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;21:e34.

Stentz FB, Brewer A, Wan J, et al. Remission of pre-diabetes to normal glucose tolerance in obese adults with high protein versus high carbohydrate diet: randomized control trial. BMJ Open Diabetes Res Care. 2016;4:e000258

Chiu THT, Pan W-H, Lin M-N, Lin C-L. Vegetarian diet, change in dietary patterns, and diabetes risk: a prospective study. NutrDiabetes. 2018;8:12.

Lee Y, Park K. Adherence to a vegetarian diet and diabetes risk: a systematic review and meta-analysis of observational studies.Nutrients. 2017;9:E603.

Qian F, Liu G, Hu FB, Bhupathiraju SN, Sun Q. Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern Med. 2019;179:1335-44.

Esposito K, Chiodini P, Maiorino MI, Bellastella G, Panagiotakos D, Giugliano D.Which diet for prevention of type 2 diabetes? A metaanalysis of prospective studies. Endocrine. 2014; 47:107-16.

Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383:1999-2007.

Jacobs S, Harmon BE, Boushey CJ, et al. A priori-defined diet quality indexes and risk of type 2 diabetes: the Multiethnic Cohort. Diabetologia. 2015;58:98-112.

Chiuve SE, Fung TT, Rimm EB, et al. Alternativedietaryindicesbothstronglypredictriskof chronic disease. J Nutr. 2012;142:1009-18.

Schwingshackl L, Bogensberger B, Hoffmann G. Diet quality as assessed by the Healthy Eating Index, Alternate Healthy Eating Index, Dietary Approaches to Stop Hypertension score, and HealthOutcomes:anupdatedsystematicreview and meta-analysis of cohort studies. J Acad Nutr Diet. 2018;118:74-100.e11

Parker AR, Byham-Gray L, Denmark R, Winkle PJ. Theeffectofmedicalnutritiontherapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlledclinicalresearchtrial. J Acad Nutr Diet. 2014;114:1739-48.

Fedewa MV, Gist NH, Evans EM, Dishman RK. Exercise and insulin resistance in youth: a metaanalysis. Pediatrics. 2014;133:e163-e174.

Davis CL, Pollock NK, Waller JL, et al. Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial. JAMA. 2012;308:1103-12.

Sigal RJ, Alberga AS, Goldfield GS, et al. Effects of aerobic training, resistance training, or both on percentage body fat and cardiometabolic risk markers in obese adolescents: the healthy eating aerobic and resistance training in youth randomized clinical trial. JAMA Pediatr 2014;168:1006-14.

Dai X, Zhai L, Chen Q, et al. Two-yearsupervised resistance training prevented diabetes incidence in people with prediabetes: a randomised control trial. Diabetes Metab Res Rev. 2019;35:e3143.

Thorp AA, Kingwell BA, Sethi P, Hammond L, Owen N, Dunstan DW. Alternating bouts of sitting and standing attenuate postprandial glucose responses. Med Sci Sports Exerc. 2014;46: 2053-61.

Healy GN, Dunstan DW, Salmon J, et al. Breaksinsedentarytime:beneficialassociations with metabolic risk. DiabetesCare. 2008;31:661-6.

Russo LM, Nobles C, Ertel KA, Chasan-Taber L, Whit­­comb BW. Physical activity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. Obstet Gynecol. 2015;125:576-82.

Herman WH, Hoerger TJ, Brandle M, et al.; Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-32.

Chen F, Su W, Becker SH, et al. Clinical and economicimpactofadigital,remotely-delivered intensive behavioral counseling program on Medicare beneficiaries at risk for diabetes and cardiovascular disease. PLoS One. 2016;11:e0163627.

Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of life style intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35:723-30.

Alva ML, Hoerger TJ, Jeyaraman R, Amico P, Rojas-Smith L. Impact of the YMCA of the USA Diabetes Prevention Program on Medicare spending and utilization. Health Aff (Millwood). 2017;36:417-24.

Zhou X, Siegel KR, Ng BP, et al. Costeffectiveness of diabetes prevention interventions targeting high-risk individuals and whole populations: a systematic review. Diabetes Care. 2020;43:1593-616.

Ackermann RT, Finch EA, BrizendineE, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008;35: 357-63.

Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physicalactivitypromotionprogramsto prevent type2diabetesamongpersonsatincreasedrisk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015; 163:437-51.

Li R, Qu S, Zhang P, et al. Economicevaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163:452-60.

Gilmer T, O’Connor PJ, Schiff JS, et al. Costeffectiveness of a community-based Diabetes Prevention Program with participation incentives for Medicaid beneficiaries. Health Serv Res. 2018;53:4704-24.

Ackermann RT, Kang R, Cooper AJ, et al. Effect on health care expenditures during nationwide implementation of the Diabetes Prevention Program as a health insurance benefit. Diabetes Care. 2019;42:1776-83.

Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention Program. Diabetes Care. 2017;40:1331-41.

Lanza A, Soler R, Smith B, Hoerger T, Neuwahl S, Zhang P. The Diabetes Prevention Impact Tool Kit: an online tool kit to assess the cost-effectivenessofpreventingtype2diabetes. J Public Health Manag Pract. 2019;25:E1-E5.

Cannon MJ, Masalovich S, Ng BP, et al. Retention among participants in the National Diabetes Prevention Program lifestyle change program, 2012–2017. Diabetes Care. 2020;43: 2042-9.

The Community Guide. Diabetes prevention: interventions engaging community health workers, 2016. Accessed 5 October 2020. Available from https://www.thecommunityguide.org/findings/ diabetes-prevention-interventions-engagingcommunity-health-workers.

Jacob V, Chattopadhyay SK, Hopkins DP, et al. Economics of community health workers for chronic disease: findings from community guide systematic reviews. Am J Prev Med. 2019; 56:e95-e106.

Raynor HA, Davidson PG, Burns H, et al. Medical nutrition therapy and weight loss questions for the Evidence Analysis Library prevention of type 2 diabetes project: systematic reviews. J Acad Nutr Diet. 2017;117:1578-611.

Sun Y, You W, Almeida F, Estabrooks P, Davy B. The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis. J Acad Nutr Diet. 2017;117:404-21.

Briggs Early K, Stanley K. Position of the Academy of Nutrition and Dietetics: the role of medical nutrition therapy and registered dietitian nutritionists in the prevention and treatment of prediabetes and type 2 diabetes. J Acad Nutr Diet. 2018;118:343-53.

Powers MA, Bardsley JK, Cypress M, et al. Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association,the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care. 2020;43: 1636-49.

Hudspeth BD. Power of prevention: the pharmacist’s role in prediabetes management. Diabetes Spectr. 2018;31:320-3.

Butcher MK, Vanderwood KK, Hall TO, Gohdes D, Helgerson SD, Harwell TS. Capacity of diabetes education programs to provide both diabetes self-management education and to implement diabetes prevention services. J Public Health Manag Pract. 2011;17:242-7.

Grock S, Ku J-H, Kim J, Moin T. A review of technology-assisted interventions for diabetes prevention. Curr Diab Rep. 2017;17:107.

Sepah SC, Jiang L, Peters AL. Translating the Diabetes Prevention Program into an online social network: validation against CDC standards. Diabetes Educ. 2014;40:435-43.

Bian RR, Piatt GA, Sen A, et al. The effect of technology-mediated diabetes prevention interventions on weight: a meta-analysis. J Med Internet Res. 2017;19:e76.

Sepah SC, Jiang L, Peters AL. Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study. J Med Internet Res. 2015;17:e92.

Moin T, Damschroder LJ, AuYoung M, et al. Results from a trial of an online diabetes prevention program intervention. Am J Prev Med. 2018;55:583-91.

Michaelides A, Major J, Pienkosz E Jr, Wood M, Kim Y, Toro-Ramos T. Usefulness of a novel mobile diabetes prevention program delivery platform with human coaching: 65-week observational follow-up. JMIR Mhealth Uhealth. 2018; 6:e93.

Kim SE, Castro Sweet CM, Cho E, Tsai J, Cousineau MR. Evaluation of a digital diabetes prevention program adapted for low-income patients, 2016-2018. Prev Chronic Dis. 2019; 27:E155.

Vadheim LM, Patch K, Brokaw SM, et al. Telehealth delivery of the diabetes prevention program to rural communities. Transl Behav Med. 2017;7:286-91.

Fischer HH, Durfee MJ, Raghunath SG, Ritchie ND. Short message service text message support for weight loss in patients with prediabetes: pragmatic trial. JMIR Diabetes. 2019;4: e12985.

Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDMTrail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072-7.

le Roux CW, Astrup A, Fujioka K, et al.; SCALE Obesity Prediabetes NN8022-1839 Study Group. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399-409.

Gerstein HC, Yusuf S, Bosch J, et al.; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) TrialInvestigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096-105.

DeFronzo RA, Tripathy D, Schwenke DC, et al. ACT NOW­Study. Pioglitazonefor diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104-15.

Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K; Voglibose Ph-3 Study Group. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet. 2009;373:1607-14.

Gerstein HC, Bosch J, Dagenais GR, et al.; ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012;367:319-28.

Holman RR, Haffner SM, McMurray JJ, et al.; NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362:1463-76.

Torgerson JS, Hauptman J, Boldrin MN, SjöströL. XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to life style changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-61.

Garvey WT, Ryan DH, Henry R, et al. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care. 2014;37:912-21.

McMurray JJ, Holman RR, Haffner SM, et al.; NAVIGATOR Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362:1477-90.

Bosch J, Yusuf S, Gerstein HC, et al.; DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006;355:1551-62.

Everett BM, Donath MY, Pradhan AD, Thuren T, Pais P, Nicolau JC, et al. Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes. J Am Coll Cardiol. 2018;29:2392-401.

Pittas AG, Dawson-Hughes B, Sheehan P, et al.; D2d Research Group. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381:520-30.

Ray KK, Colhoun HM, Szarek M, et al.; ODYSSEY OUTCOMES Committees and Investigators.Effectsofalirocumaboncardiovascularand metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7:618-28.

Diabetes Prevention Program Research Group. Long-termsafety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012;35:731-7.

Ratner RE, Christophi CA, Metzger BE, et al.; Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93:4774-9.

Aroda VR, ChristophiCA, Edelstein SL, et al.; Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program Outcomes Study 10-year follow-up. J Clin Endocrinol Metab. 2015;100:1646-53.

Diabetes Prevention Program Research Group. Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Dia­­betes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2019;42:601-8.

Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme [IDPP]. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type2 diabetes in Asian Indian subjects with impaired glucose tolerance [IDPP-1]. Diabetologia. 2006; 49:289-97.

Griffin SJ, Bethel MA, Holman RR, et al. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Health Technol Assess. 2018;22:1-64.

Aroda VR, Edelstein SL, Goldberg RB, et al.; Diabetes Prevention Program Research Group. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016; 101:1754-61.

Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol. 2018;6:392-403.

Pan Y, Chen W, Wang Y. Prediabetes and outcomeofischemicstrokeortransientischemic attack: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2019;28:683-92

Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.

Yeh H-C, Duncan BB, Schmidt MI, Wang N-Y, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152:10-7.

Oba S, Noda M, Waki K, et al.; Japan Public Health Center-based Prospective Study Group. Smoking cessation increases short-term risk of type 2 diabetes irrespective of weight gain: the Japan Public Health Center-Based Prospective Study [published correction appearsin PLoS One 2013;8:10.1371 /annotation/23aa7c42-9a4d42a7-8f50-9d0ac4b85396]. PLoSOne. 2012;7: e17061.

Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, et al. Smoking cessation, weight change, type 2 diabetes, and mortality. N Engl J Med. 2018;379:623-32.

Orchard TJ, Temprosa M, Barrett-Connor E, et al.; Diabetes Prevention Program Outcomes StudyResearchGroup.Long-termeffectsofthe Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med. 2013;30:46-55.

Salas-Salvado J, Dıaz-Lopez A, Ruiz-Canela M, et al.; PREDIMED-Plus investigators. Effect of a lifestyle intervention program with energyrestricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus Trial. Diabetes Care. 2019;42:777-88.

Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54:300-7.

Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596-e646.




Як цитувати

Американська діабетична асоціація. Стандарти медичної допомоги при діабеті-2021. Глава 3. Профілактика або відтермінування діабету 2 типу. КЕтаЕХ [інтернет]. 16, Грудень 2021 [цит. за 13, Липень 2024];(4):66-74. доступний у: http://jcees.endocenter.kiev.ua/article/view/247246



Стандарти та консенсуси